Don't get left behind! The modernized is coming. Check it out now.
Say goodbye to!
The new site is coming soon - go to the modernized
Working… Menu

Safety and Efficacy Study of Sintilimab Combined With IBI305 in Patients With Advanced Hepatocellular Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04072679
Recruitment Status : Completed
First Posted : August 28, 2019
Last Update Posted : February 1, 2021
Information provided by (Responsible Party):
Aiping Zhou, Cancer Institute and Hospital, Chinese Academy of Medical Sciences

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 31, 2020
Actual Study Completion Date : November 11, 2020